Soft Tissue Tumors

Cancer Cytogenetics

Volumn , Issue , 2010, Pages 675-711

  Mandahl, Nils ^a   Mertens, Fredrik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Adipose tissues; Adlpocytlc tumors; Clonal chromosome aberrations; Soft tissue tumors; Supernumerary ring chromosomes

Indexed keywords

EID: 77955504974     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118010136.ch23     Document Type: Chapter

References (146)

1. Abbott JJ, Erickson-Johnson M, Wang X, Nascimento AG, Oliveira AM (2006): Gains of COL1 Al-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mod Pathol 19:1512-1518.
2. Alaggio R, Rosolen A, Sartori F, Leszl A, d'Amore ESG, Bisogno G, Carli M, Cecchetto G, Coffin CM, Ninfo V (2007): Spindle cell tumor with EWS-WT1 transcript and a favorable clinical course: a variant of DSCT, a variant of leiomyosarcoma, or a new entity? Report of 2 pediatric cases. Am J Surg Pathol 31:454-459.
3. Amary MFC, Berisha F, Del Carlo Bernard F, Herbert A, James M, Reis-Filho JS, Fisher C, Nicholson AG, Tirabosco R, Diss TC, Flanagan AM (2007): Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol 20:482-496.
4. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M (2001): Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopatho-logic study of 82 cases. Clin Cancer Res 7:3977-3987.
5. Antonescu CR, Nafa K, Segal NH, Dal Cin P, Ladanyi M (2006): EWS-CREB1: a recurrent variant fusion in clear cell sarcoma-association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 12:5356-5362.
6. Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, Ladanyi M (2007): EWSR1 -CREB is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 46:1051-1060.
7. Arlotta P, Tai AK-F Manfioletti G, Clifford C, Jay G, Ono SJ (2000): Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem 275:14394-14400.
8. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K. (1995): Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
9. Aulmann S, Longerich T, Schirmacher P, Mechtersheimer G, Penzel R (2007): Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas. Histopathology 50:881-886.
10. Barr FG (2001): Gene fusions involving PAX and FOX family members in alveolar rhabdomyosar-coma. Oncogene 20:5736-5746.
11. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PHB (2002): Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 62:4704-4710.
12. Bartuma H, Hallor KH, Panagopoulos I, Collin A, Rydholm A, Gustafson P, Bauer HCF, Brosjo O, Domanski HA, Mandahl N, Mertens F (2007): Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer 46:594-606.
13. Baumhoer D, Gunawan B, Becker H, Fiizesi L (2005): Comparative genomic hybridization in four angiosarcomas of the breast. Gynecol Oncol 97:348-352.
14. Berner J-M, Forus A, Elkahloun A, Meltzer PS, Fodstad Ö, Myklebost O (1996): Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 17:254-259.
15. Bode-Lesniewska B, Frigerio S, Exner U, Abdou MT, Moch H, Zimmerman DR (2007): Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion. Genes Chromosomes Cancer 46:961-97 1.
16. Brandal P, Micci F, Bjerkehagen B, Eknas M, Larramendy M, Lothe RA, Knuutila S, Heim S (2003): Molecular cytogenetic characterization of desmoid tumors. Cancer Genet Cytogenet 146:1-7.
17. Bridge JA, Borek DA, Neff JR, Huntrakoon M (1990): Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol 93:26-31.
18. Bridge JA, Liu J, Qualman SJ, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker KS, Sorensen P, Barr FG (2002): Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyo-sarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33:310-321.
19. Broberg K, Zhang M, Strombeck B, lsaksson M, Nilsson M, Mertens F, Mandahl N, Panagopoulos I (2002): Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12ql3-15. fnt J Oncol 21:321-326.
20. Carneiro A, Francis P, Bendahl P-O, Fernebro J, Akerman M, Fletcher C, Rydholm A, Borg A, Nilbert M (2009): Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? Lab Invest, in press.
21. Chang A, Schuetze SM, Conrad EU III, Swisshelm KL, Norwood TH, Rubin BP (2005): So-called "inflammatory leiomyosarcoma": a series of 3 cases providing additional insights into a rare entity. Int J Surg Pathol 13:185-195.
22. Chibon F, Mariani O, Derre J, Malinge S, Coindre J-M, Guillou L, Lagace R, Aurias A (2002): A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 139:24-29.
23. Coindre J-M, Hostein I, Maire G, Derre J, Guillou L, Leroux A, Ghnassia J-P, Collin F, Pedeutour F, Aurias A (2004): Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203:822-830.
24. Crombez KRMO, Vanoirbeek EMR, Van de Ven WJM, Petit MMR (2005): Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2. Mol Cancer Res 3:63-70.
25. Crozat A, Aman P, Mandahl N, Ron D (1993): Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640-644.
26. Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O'Connell JX, Huntsman D, van de Rijn M, Gilks CB, West BR (2007): Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 31:970-976.
27. Dahlen A, Debiec-Rychter M, Pedeutour F, Domanski HA, Hoglund M, Bauer HCF, Rydholm A, Sciot R, Mandahl N, Mertens F (2003): Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 103:616-623.
28. Dal Cin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W, Van Den Berghe H (1993): Cylogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 68:85-90.
29. Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ, Anderson MJ (2006): Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66:6936-6946.
30. De Cecco L, Gariboldi M, Reid JF, Lagonigro MS, Tamborini E, Albertini V, Staurengo S, Pilotti S, Pierotti MA (2005): Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript. Histopathology 46:334-341.
31. Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CDM, Tallini G (2000): Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumors. J Pathol 190:531-536.
32. De Wever I, Dal Cin P, Fletcher CDM, Mandahl N, Mortens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Vanni R, Willen H (2000): Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP study group. Mod Pathol 13:1080-1085.
33. Douglass EC, Shapiro DN, Valentine M, Rowe ST, Carroll AJ, Raney RB, Ragab AH, Abella SM, Parham DM (1993): Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21:83-87.
34. Fletcher JA, Naeem R, Xiao S, Corson JM (1995): Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 79:139-143.
35. Fletcher CDM, Gustafson P, Rydholm A, Akerman M (2001): Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19:3045-3050.
36. Fletcher CDM, Unni KK, Mertens F, editors (2002): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press.
37. Folpe AL, Deyrup AT (2006): Alveolar soft-part sarcoma: a review and update. J Clin Pathol 59:1127-1132.
38. Gerald WL, Haber DA (2005): The EWS-WTI gene fusion in desmoplastic small round cell tumor. Semin Cancer Bioi 15:197-205.
39. Gisselsson D, Hoglund M, Mertens F, Mitelman F, Mandahl N (1998): Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 23:203-212.
40. Gisselsson D, Hoglund M, Mertens F, Dal Cin P, Mandahl N (1999): Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics. Am J Pathol 155:61-66.
41. Gisselsson D, Hibbard MK, Dal Cin P, Sciot R, Hsi B-L, Kozakewich HP, Fletcher JA (2001): PLAG1 alterations in lipoblastoma. Involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol 159:955-962.
42. Gordon T, McManus A, Anderson J, Min T, Swansbury J, Pritchard-Jones K, Shipley J (2001): Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom cancer cytogenetics group study. Med Pediatr Oncol 36:259-267.
43. Guillou L, Benhattar J, Binichon F, Gallagher G, Terrier P, Stauffer E, de Saint Aubain Somerhausen N, Michels J-J, Jundt G, Ranchere Vince D, Taylor S, Genevay M, Collin F, Trassard M, Coindre J-M (2004): Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol 22:4040-4050.
44. Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchere-Vince D, Collin F, Terrier P, Terrier-Lacombe M-J, Leroux A, Marques B, de Saint Aubain Somerhausen N, Keslair F, Pedeutour F, Coindre J-M (2007): Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma. A study from the French sarcoma group. Am J Surg Pathol 31:1387-1402.
45. Hallor KH, Micci F, Meis-Kindblom JM, Kindblom L-G, Bacchini P, Mandahl N, Mertens F, Panagopoulos I (2007): Fusion genes in angiomatoid fibrous histiocytoma. Cancer Lett 251:158-163.
46. Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HCF, Astrom K, Domanski HA, Meis JM, Kindblom L-G, Panagopoulos I, Mandahl N. Mertens F (2009): Two genetic pathways, t(1; 10) and amplification of 3pl 1-12, in myxoinflammatory fibroblastic sarcoma, hemosiderotic fibro hemosiderotic fibro. Iipomatous tumor and morphologically similar lesions. J Pathol, in press.
47. Heidenblad M, Hallor KH, Staaf J, Jonsson G, Borg A, Hoglund M, Mertens F, Mandahl N (2006): Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene 25:7106-7116.
48. Hibbard MK, Kozakewich HP, Dal Cin P, Sciot R, Tan X, Xiao S, Fletcher JA (2000): PLAG1 fusion oncogenes in lipoblastoma. Cancer Res 60:4869-4872.
49. Hisaoka M, Hashimoto H (2005): Extraskeletal my xoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int 55:453-463.
50. Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pelissier S, Coindre JM (2004): Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 202:95-102.
51. Hu J, Rao LJNM, Jasani S, Khanna V, Yaw K, Surti U (2005): Loss of DNA copy number of lOq is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 161:20-27.
52. Huang H-Y, Lui MY, Ladanyi M (2005): Nonrandom cell-cycle timing of a somatic chromosomal translocation: the t(X; 17) of alveolar soft part sarcoma occurs in G2. Genes Chromosomes Cancer 44:170-176.
53. Idbaih A, Coindre J-M, Derre J, Mariani O, Terrier P, Ranchere D, Mairal A, Aurias A (2005): Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 85:176-181.
54. Kawashima H, Ogose A, Umezu H, Hotta T, Tohyama T, Tsuchiya M, Endo N (2007): Ossifying fibromyxoid tumor of soft parts with clonal chromosomal aberrations. Cancer Genet Cytogenet 176:156-160.
55. Kazmierczak B, Dal Cin P, Wanschura S, Bartnitzke S, Van den Berghe H, Bullerdiek J (1998): Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors. Am J Pathol 152:431-435.
56. Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J, Kere J, Miettinen M, Knuutila S (2001): Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 92:192-195.
57. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PHB (1998): A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184-187.
58. Kouho H, Aoki T, Hisaoka M, Hashimoto H (1997): Clinicopathological and interphase cytogenetic analysis of desmoid tumors. Histopathology 31:336-341.
59. Kullendorff CM, DonnerM, Mertens F, Mandahl N (1998): Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol 30:156-159.
60. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PHB, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge JA (2001): The der(17)t(X;17)(pl I;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20:48-57.
61. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JSJ, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O (2002): Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62:135-140.
62. Lae ME, Roche PC, Jin L, Lloyd RV, Nascimento AG (2002): Desmoplastic small round cell tumor. A clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 26:823-835.
63. Lae M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M (2007): Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol 212:143-151.
64. Lairamendy ML, Virolainen M, Tukiainen E, Elomaa I, Knuutila S (1998): Chromosome band Iq21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer 23:183-186.
65. Larramendy ML, Kaur S, Svarvar C, Bohling T, Knuutila S (2006): Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization. Cancer Genet Cyto-genet 169:94-101.
66. Larramendy ML, Gentile M, Soloneski S, Knuutila S, Bohling T (2008): Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma? Cancer Genet Cytogenet 187:1-11.
67. Lee YS, Dutta A (2007): The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2:025-1030.
68. Li X-Q, Hisaoka M, Shi D-R, Zhu X-Z, Hashimoto H (2004): Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Hum Patfio/35:711-721.
69. Ligon AH, Moore SDP, Parisi MA, Mealiffe ME, Harris DJ, Ferguson HL, Quade BJ, Morton CM (2005): Constitutional rearrangement of the architectural factor HMGA2: a novel human pheno-type including overgrowth and lipomas. Am J Hum Genet 76:340-348.
70. Limon J, Mrozek K, Mandahl N, Nedoszytko B, Verhest A, Rys J, Niezabitowski A, Babinska M, Nosek H, Ochalek T, Kopacz A, Willen H, Rydholm A, Heim S, Mitelman F (1991): Cytogenetics of synovia! sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3:338-345.
71. Loh WE Jr, Scrable HJ, Livanos E, Arboleda MJ, Cavenee WK, Oshimura M, Weissman BE (1992): Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdo-myosarcoma. Proc Natl Acad Sci USA 89:1755-1759.
72. Lualdi E, Modena P, Debiec-Rychter M, Pedeutour F, Teixeira MT, Facchinetti F, Dagrada GP, Pilotti S, Sozzi G (2004): Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer 41:283-290.
73. Maire G, Forus A, Foa C, Bjerkehagen B, Mainguene C, Kresse SH, Myklebost O, Pedeutour F (2003): Ilql3 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 1 Iql3.5. Genes Chromosomes Cancer 37:389-395.
74. Mandahl N, Heim S, Willen H, Rydholm A, Mitelman F (1990): Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49:273-275.
75. Mandahl N, Hoglund M, Mertens F, Rydholm A, Willen H, Brosjo O, Mitelman F (1994a): Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 9:207-215.
76. Mandahl N, Mertens F, Willen H, Rydholm A, Brosjo O, Mitelman F (1994b): A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas. J Cancer Res Clin Oncol 120:707-711.
77. Mandahl N, Limon J, Mertens F, Nedoszytko B, Gibas Z, Denis A, Willen H, Rydholm A, Szadowska A, Kreicbergs A, Rys J, Debiec-Rychter M, Mitelman F (1995): Nonrandom secondary chromosome aberrations in synovial sarcomas with t(X;18). Int J Oncol 7:495-499.
78. Mandahl N, Akerman M, Aman P, Dal Cin P, De Wever I, Fletcher CDM, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Van de Ven W, Vanni R, Willen H (1996): Duplication of chromosome segment 12q 15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. Int J Cancer 67:632-635.
79. Mandahl N, Mertens F, Willen H, Rydholm A, Kreicbergs A, Mitelman F (1998): Nonrandom pattern of telomeric associations in atypical lipomatous tumors with ring and giant marker chromosomes. Cancer Genet Cytogenet 103:25-34.
80. Mandahl N, Fletcher CDM, Dal Cin P, De Wever I, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Vanni R, Willen H (2000): Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP study group. Cancer Genet Cytogenet 116:66-73.
81. Matsuyama A, Hisaoka M, Shimajiri S, Hayashi T, Imamura T, Ishida T, Fukunaga M, Fukuhara T, Minato H, Nakajima T, Yonezawa S, Kuroda M, Yamasaki F, Toyoshima S, Hashimoto H (2006): Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol 30:1077-1084.
82. McArthur GA, Demetri GD, van Oosterom Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Retcher JA (2005): Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study B2225. J Clin Oncol 23:866-873.
83. McComb EN, Feely MG, Neff JR, Johansson SL, Nelson M, Bridge JA (2001): Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer Genet Cytogenet 126:68-72.
84. Meis-Kindblom JM, Sjogren H, Kindblom L-G, Peydro-Mellquist A, Roijer E, Aman P, Stenman G (2001): Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch 439:141-151.
85. Mendlick MR, Nelson M, Pickering D, Johansson SL, Seemayer TA, Neff JR, Vergara G, Rosenthal H, Bridge JA (2001): Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol 25:684-687.
86. Mertens F, Retcher CDM, Dal Cin P, De Wever I, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Vanni R, Willen H (1998): Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP study group. Genes Chromosomes Cancer 22:16-25.
87. Mertens F, Fletcher CDM, Antonescu CR, Coindre J-M, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N, Panagopoulos I (2005): Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Uib Invest 85:408-115.
88. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Florenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O (2002): Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in Iq21. Oncogene 21:2261-2269.
89. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namlos HM, Wang J, Kristiansen BE, Myklebost O (2006): Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66:8984-8993.
90. Micci F, Teixeira MR, Bjerkehagen B, Heim S (2002): Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH. Cytogenet Genome Res 97:13-19.
91. Micci F, Panagopoulos I, Bjerkehagen B, Heim S (2006): Deregulation of HMGA2 in an aggressive angiomyxoma with t(l 1;12)(q23;ql5). Virchows Arch 448:838-842.
92. Miettinen MM, el-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S (1997): Tumor size-related DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas. Mod Pathol 10:1194-1200.
93. Mitelman F, Johansson B, Mertens F, editors (2008): Mitelman Database of Chromosome Aberrations in Cancer. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman.
94. Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, Sozzi G (2005): SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 65:4012-4019.
95. Moller E, Mandahl N, Mertens F, Panagopoulos I (2008): Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors. Genes Chromosomes Cancer 47:21-25.
96. Nakagawa Y, Numoto K, Yoshida A, Kunisada T, Ohata H, Takeda K, Wai D, Poremba C, Ozaki T (2006): Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization. J Cancer Res Clin Oncol 132:444-450.
97. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T (2007): Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 20:749-759.
98. Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O, Mandahl N (2004): Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas, lnt J Cancer 109:363-369.
99. Nilsson M, Panagopoulos I, Mertens F, Mandahl N (2005): Fusion of the HMGA2 and NFIB genes in lipoma. VirchowsArch 447:855-858.
100. Nilsson M, Mertens F, Hoglund M, Mandahl N, Panagopoulos I (2006): Truncation and fusion of HMGA2 in lipomas with rearrangements of 5q32-q33 and 12ql4-ql5. Cytogenet Genome Res 112:60-66.
101. Nishio J, Iwasaki H, Ohjimi Y, Ishiguro M, Kobayashi K, Nabeshima K, Naito M, Kikuchi M (2004): Chromosomal imbalances in angioleiomyomas by comparative genomic hybridization, lnt J Mol Med 13:13-16.
102. Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA (2006): Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest 86:547-556.
103. O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP (1998): Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23:187-193.
104. Ohguri T, Hisaoka M, Kawauchi S, Sasaki K, Aoki T, Kanemitsu S, Matsuyama A, Korogi Y, Hashimoto H (2006): Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation. J Clin Pathol 59:978-983.
105. Orndal C, Rydholm A, Willen H, Mitelman F, Mandahl N (1994): Cytogenetic intratumor heterogeneity in soft tissue tumors. Cancer Genet Cytogenet 78:127-137.
106. Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P (1996): Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 12:489-494.
107. Panagopoulos I, Mertens F, Isaksson M, Mandahl N (2000): A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Biophys Res Commun 279:838-845.
108. Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Debiec-Rychter M, Szadowska A, Brosjo O, Larsson O, Rydholm A, Mandahl N (2001): Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31:362-372.
109. Panagopoulos I, Mertens F, Debiec-Rychter M, Isaksson M, Limon J, Kardas I, Domanski HA, Sciot R, Perek D, Crnalic S, Larsson O, Mandahl N (2002a): Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of the tendons and aponeuroses. lnt J Cancer 99:560-567.
110. Panagopoulos I, Mertens F, Isaksson M, Domanski HA, Brosjo O, Heim S, Bjerkehagen B, Sciot R, Dal Cin P, Fletcher JA, Fletcher CDM, Mandahl N (2002b): Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 35:340-352.
111. Panagopoulos I, Storlazzi CT, Fletcher CDM, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjo O, Rydholm A, Isaksson M, Mandahl N, Mertens F (2004): The chimeric FUS/CREB3L2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 40:218-228.
112. Patel AS, Murphy KM, Hawkins AL, Cohen JS, Long PP, Perlman EJ, Griffin CA (2007): RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 176:107-114.
113. Pedeutour F, Coindre J-M, Sozzi G, Nicolo G, Leroux A, Toma S, Miozzo M, Bouchot C, Hecht F, Ayraud N, Turc-Carel C (1994): Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet 76:1-9.
114. Pedeutour F, Forus A, Coindre J-M, Berner J-M. Nicolo G, Michiels J-F, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C (1999): Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30-41.
115. Petit MMR, Mols R, Schoenmakers EFPM, Mandahl N, Van de Ven WJM (1996): LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics 36:118-129.
116. Petit MMR, Schoenmakers EFPM, Huysmans C, Geurts JMW, Mandahl N, Van de Ven WJM (1999): LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 57:438-441.
117. Rabban JT, Dal Cin P, Oliva E (2006): HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma. Int J Gynecol Pathol 25:403-407.
118. Rabbitts TH, Forster A, Larson R, Nathan P (1993): Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4:175-180.
119. Rieker RJ, Joos S, Bartsch C, Willeke F, Schwarzbach M, Otano-Joos M, Ohl S, Hogel J, Lehnert T, Lichter P, Otto HF, Mechtersheimer G (2002): Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int J Cancer 99:68-73.
120. Rubin BP, Chen C-J, Morgan TW, Xiao S, Grier HE, Kozakewich HP, Perez-Atayde AR, Fletcher JA (1998): Congenital mesoblastic nephroma t(12; 15) is associated with ETV6-NTRK3 gene fusion. Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 153:1451-1458.
121. Sandberg AA (2004): Genetics of chondrosarcoma and related tumors. Curr Opin Oncol 16:342-354.
122. Sandberg AA, Bridge JA (2002): Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: alveolar soft part sarcoma. Cancer Genet Cytogenet 136:1-9.
123. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM (1995): Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-444.
124. Sciot R, Akerman M. Dal Cin P, De Wever L Fletcher CDM, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Tallini G, Van den Berghe H, Vanni R, Willen H (1997): Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas. A report of the CHAMP study group. Am J Surg Pathol 21:441-444.
125. Sciot R, Rosai J, Dal Cin P, de Wever L Fletcher CDM, Mandahl N, Mertens F, Mitelman F, Rydholm A, Tallini G, van den Berghe H, Vanni R, Willen H (1999): Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the chromosomes and morphology (CHAMP) study group. Mod Pathol 12:576-579.
126. Simon M-P, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre J-M, Terrier-Lacombe M-J, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, Guilbaud C, Dumanski JP (1997): Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15:95-98.
127. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, Geurts van Kessel A, Suijkerbuijk R (2000): Frequent loss of 9p21 (pl6INK4A) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 118:89-98.
128. Singer S, Socci ND, Ambrosini G, Sambol E, Decarolis P, Wu Y, O Connor R, Agnes Viale RM, Sander C, Schwartz GK, Antonescu CR (2007): Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67:6626-6636.
129. Sjogren H, Meis-Kindblom JM, Orndal C, Bergh P, Ptaszynski K, Aman P, Kindblom L-G, Stenman G (2003): Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma- cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol 162:781-792.
130. Skytting BT, Szymanska J, Aalto Y, Lushnikova T, Blomqvist C, Elomaa I, Larsson O, Knuutila S (1999): Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 115:39-46.
131. Slater O, Shipley J (2007): Clinical relevance of molecular genetics to paediatric sarcomas. J Clin Pathol 60:1187-1194.
132. Sorensen PHB, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG (2002): PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20:2672-2679.
133. Sreekantaiah C, Leong SPL, Karakousis CP, McGee DL, Rappaport WD, Villar HV, Neal D, Fleming S, Wankel A, Herrington PN, Carmona R, Sandberg AA (1991): Cytogenetic profile of 109 lipomas. Cancer Res 51:422-V33.
134. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, Dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ, Alman BA (1999): Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615-6620.
135. Turc-Carel C, Limon J, Dal Cin P, Rao U, Karakousis C, Sandberg AA (1986): Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(ql3;pl 1) in myxoid lipo-sarcomas. Cancer Genet Cytogenet 23:291-299.
136. Turc-Carel C, Dal Cin P, Limon J, Rao U, Li FP, Corson JM, Zimmerman R, Parry DM, Cowan JM, Sandberg A A (1987): Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl AcadSci USA 84:1981-1985.
137. Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Biihlmann P, Niggli FK, Schafcr BW (2004): Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64:5539-5545.
138. Wang R, Lu Y-J, Fisher C, Bridge JA, Shipley J (2001): Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 31:54-64.
139. Wang R, Titley JC, Lu Y-J, Summersgill BM, Bridge JA, Fisher C, Shipley J (2003): Loss of 13ql 4-q21 and gain of 5pl4-pter in the progression of leiomyosarcoma. Mod Pathol 16:778-785.
140. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M (2006): A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA 103:690-695.
141. Willeke F, Ridder R, Mechtersheimer G, Schwarzbach M, Duwe A, Weitz J, Lehnert T, Herfarth C, von Knebel Doeberitz M (1998): Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications. Clin Cancer Res 4:1779-1784.
142. Willems SM, Debiec-Rychter M, Szuhai K, Hogendoorn PCW, Sciot R (2006): Local recurrence of myxofibrosarcoma is associated with increase in tumor grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol 19:407-416.
143. Xia SJ, Pressey JG, Barr FG (2002): Molecular pathology of rhabdomyosarcoma. Cancer Biol Ther 1:97-104.
144. Zaidi MR, Okada Y, Chada KK (2006): Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. Cancer Res 66:7453-7459.
145. Zhang H, MacDonald WD, Erickson-Johnson M, Wang X, Jenkins RB, Oliveira AM (2007): Cytogenetic and molecular cytogenetic findings of intima) sarcoma. Cancer Genet Cytogenet 179:146-149.
146. Zhao J, Roth J, Bode-Lesniewska B, Pfaltz M, Heitz PU, Komminoth P (2002): Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes Cancer 34:48-57.